Stockscreener 앱 받기
1.16
0.43%
-0.01
Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스
What is Northland Securities' Forecast for HRTX Q1 Earnings? - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
HRTX Should I Buy - Intellectia AI
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2025 Earnings Call Transcript - Insider Monkey
What is HC Wainwright's Estimate for HRTX Q1 Earnings? - MarketBeat
HRTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Heron Therapeutics (NASDAQ:HRTX) Issues Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Heron Therapeutics: Profitable Growth Outlook and Acute Care Momentum Underpin Buy Rating and $3 Target - TipRanks
Heron Therapeutics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Heron Therapeutics outlines $173M–$183M 2026 sales targets amid acute care momentum and expanded commercial investment - MSN
Heron Therapeutics Q4 Earnings Call Highlights - MarketBeat
Heron Therapeutics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:HRTX) 2026-02-26 - Seeking Alpha
Key facts: Heron Therapeutics projects $173-$183M revenue by 2026; ZYNRELEF adoption rises; credit facilities expanded - TradingView
Heron Therapeutics (HRTX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Heron Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Heron Therapeutics, Inc. Provides Earnings Guidance for the Year 2026 - marketscreener.com
Earnings call transcript: Heron Therapeutics Q4 2025 reports strong growth By Investing.com - Investing.com Canada
Heron Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
HRTX: 2025 net revenue rose 7.4% to $154.9M, with strong Acute Care growth and positive EBITDA - TradingView
HERON THERAPEUTICS ($HRTX) Releases Q4 2025 Earnings - Quiver Quantitative
Heron Therapeutics: Fourth Quarter Earnings Overview - Bitget
Heron Therapeutics: Q4 Earnings Snapshot - marketscreener.com
HERON THERAPEUTICS, INC. /DE/ SEC 10-K Report - TradingView
HRTX: 2025 net revenue rose 7.4% to $154.9M, driven by Acute Care growth and new CMS J-Codes - TradingView
Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results - TradingView
Heron Therapeutics (HRTX) TTM Loss Of US$20.2 Million Tests Profitability Turnaround Narrative - Sahm
Aug Sectors: Whats Heron Therapeutics Incs historical returnWeekly Profit Recap & Technical Pattern Based Signals - baoquankhu1.vn
Heron Therapeutics Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring A Potential Upside Of 258.13% - DirectorsTalk Interviews
Heron Therapeutics, Inc. $HRTX Shares Acquired by JW Asset Management LLC - MarketBeat
Heron Therapeutics (HRTX) Expected to Announce Earnings on Thursday - MarketBeat
Aug EndMonth: What are JOFF Fintech Acquisition Corp Debt Equity Composite Unitss growth leversMarket Trend Report & Verified Entry Point Detection - baoquankhu1.vn
MSN Money - MSN
Heron: Near The Bottom Of A Trading Range Despite Positives (NASDAQ:HRTX) - Seeking Alpha
Clearline Capital reports 6.7% Heron Therapeutics stake (HRTX) - Stock Titan
Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026 - The Manila Times
Should I set a stop loss on Heron Therapeutics Inc.Dollar Strength & Entry Point Confirmation Signals - mfd.ru
Can Heron Therapeutics Inc. expand into new marketsWeekly Risk Report & Breakout Confirmation Trade Signals - mfd.ru
How does Heron Therapeutics Inc. compare to its peersJuly 2025 Weekly Recap & Community Consensus Trade Alerts - mfd.ru
How strong is Heron Therapeutics Inc. (AXD2) stock earnings growthJuly 2025 WrapUp & Safe Capital Growth Tips - mfd.ru
How resilient is Heron Therapeutics Inc. stock in market downturnsJuly 2025 Rallies & Free Accurate Trade Setup Notifications - mfd.ru
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Here's Why Heron Therapeutics (NASDAQ:HRTX) Has A Meaningful Debt Burden - simplywall.st
Is Heron Therapeutics Inc. impacted by rising rates2025 Market Outlook & Weekly Hot Stock Watchlists - mfd.ru
Is Heron Therapeutics Inc. stock a good dividend stock2025 Analyst Calls & Daily Technical Stock Forecast Reports - mfd.ru
New York State Common Retirement Fund Buys 816,671 Shares of Heron Therapeutics, Inc. $HRTX - MarketBeat
Heron Therapeutics, Inc. (HRTX): Investor Outlook Reveals Potential 240.91% Upside - DirectorsTalk Interviews
Heron Therapeutics (NASDAQ:HRTX) & Enliven Therapeutics (NASDAQ:ELVN) Head to Head Contrast - Defense World
Heron Therapeutics (NASDAQ:HRTX) Shares Pass Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Heron Therapeutics (HRTX) awards EVP new RSUs and PSUs - Stock Titan
Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring A 238% Upside Potential - DirectorsTalk Interviews
Investment Report: What are the risks of holding Heron Therapeutics Inc2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
What are the risks of holding Heron Therapeutics IncTrade Entry Report & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Heron Therapeutics (NASDAQ:HRTX) Stock Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Stock Passes Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Breakeven Is Near for Heron Therapeutics, Inc. (NASDAQ:HRTX) - Yahoo Finance
Aug Technicals: Is Heron Therapeutics Inc impacted by rising ratesQuarterly Investment Review & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
0.14%
0.19%
자본화:
|
볼륨(24시간):